These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11315561

  • 1. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
    Papagiannopoulou D, Pirmettis I, Maina T, Pelecanou M, Nikolopoulou A, Chiotellis E, Raptopoulou CP, Vlahos AT, Terzis A, Papadopoulos M, Chiotellis E.
    J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
    [Abstract] [Full Text] [Related]

  • 2. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.
    León A, Rey A, Mallo L, Pirmettis I, Papadopoulos M, León E, Pagano M, Manta E, Incerti M, Raptopoulou C, Terzis A, Chiotellis E.
    Nucl Med Biol; 2002 Feb; 29(2):217-26. PubMed ID: 11823127
    [Abstract] [Full Text] [Related]

  • 3. Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.
    Tsoukalas C, Pirmettis I, Patsis G, Pelecanou M, Bodo K, Raptopoulou CP, Terzis A, Papadopoulos M, Chiotellis E.
    J Inorg Biochem; 2003 Jan 15; 93(3-4):213-20. PubMed ID: 12576284
    [Abstract] [Full Text] [Related]

  • 4. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
    Papagiannopoulou D, Pirmettis I, Tsoukalas Ch, Nikoladou L, Drossopoulou G, Dalla C, Pelecanou M, Papadopoulou-Daifotis Z, Papadopoulos M, Chiotellis E.
    Nucl Med Biol; 2002 Nov 15; 29(8):825-32. PubMed ID: 12453592
    [Abstract] [Full Text] [Related]

  • 5. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
    Bouziotis P, Pirmettis I, Pelecanou M, Raptopoulou CP, Terzis A, Papadopoulos M, Chiotellis E.
    Chemistry; 2001 Sep 03; 7(17):3671-80. PubMed ID: 11575768
    [Abstract] [Full Text] [Related]

  • 6. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
    Mastrostamatis SG, Papadopoulos MS, Pirmettis IC, Paschali E, Varvarigou AD, Stassinopoulou CI, Raptopoulou CP, Terzis A, Chiotellis E.
    J Med Chem; 1994 Sep 30; 37(20):3212-8. PubMed ID: 7932548
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.
    Papachristou M, Pirmettis IC, Tsoukalas C, Papagiannopoulou D, Raptopoulou C, Terzis A, Stassinopoulou CI, Chiotellis E, Pelecanou M, Papadopoulos M.
    Inorg Chem; 2003 Sep 08; 42(18):5778-84. PubMed ID: 12950229
    [Abstract] [Full Text] [Related]

  • 8. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations.
    Johannsen B, Scheunemann M, Spies H, Brust P, Wober J, Syhre R, Pietzsch HJ.
    Nucl Med Biol; 1996 May 08; 23(4):429-38. PubMed ID: 8832697
    [Abstract] [Full Text] [Related]

  • 9. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
    Tsoukalas C, Papadopoulos MS, Maina T, Pirmettis IC, Nock BA, Raptopoulou C, Terzis A, Chiotellis E.
    Nucl Med Biol; 1999 Apr 08; 26(3):297-304. PubMed ID: 10363801
    [Abstract] [Full Text] [Related]

  • 10. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
    Pirmettis IC, Papadopoulos MS, Chiotellis E.
    J Med Chem; 1997 Aug 01; 40(16):2539-46. PubMed ID: 9258360
    [Abstract] [Full Text] [Related]

  • 11. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.
    Friebe M, Mahmood A, Bolzati C, Drews A, Johannsen B, Eisenhut M, Kraemer D, Davison A, Jones AG.
    J Med Chem; 2001 Sep 13; 44(19):3132-40. PubMed ID: 11543682
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligand.
    Pirmettis I, Patsis G, Pelecanou M, Tsoukalas C, Papadopoulos A, Raptopoulou CP, Terzis A, Papadopoulos M, Chiotellis E.
    Bioorg Med Chem Lett; 2001 Jul 23; 11(14):1859-62. PubMed ID: 11459647
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and characterization of mixed-ligand oxorhenium complexes with the SNN type of ligand. Isolation of a novel ReO[SN][S][S] complex.
    Rey A, Pirmettis I, Pelecanou M, Papadopoulos M, Raptopoulou CP, Mallo L, Stassinopoulou CI, Terzis A, Chiotellis E, León A.
    Inorg Chem; 2000 Sep 18; 39(19):4211-8. PubMed ID: 11196913
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
    Heimbold I, Drews A, Kretzschmar M, Varnäs K, Hall H, Halldin C, Syhre R, Kraus W, Pietzsch HJ, Seifert S, Brust P, Johannsen B.
    Nucl Med Biol; 2002 May 18; 29(4):375-87. PubMed ID: 12031872
    [Abstract] [Full Text] [Related]

  • 15. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
    Tzanopoulou S, Pirmettis IC, Patsis G, Raptopoulou C, Terzis A, Papadopoulos M, Pelecanou M.
    Inorg Chem; 2006 Jan 23; 45(2):902-9. PubMed ID: 16411729
    [Abstract] [Full Text] [Related]

  • 16. Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluation.
    Papadopoulos M, Nock B, Maina T, Pirmettis I, Raptopoulou C, Tasiopoulos A, Troganis A, Kabanos T, Terzis A, Chiotellis E.
    J Biol Inorg Chem; 2001 Feb 23; 6(2):159-65. PubMed ID: 11293409
    [Abstract] [Full Text] [Related]

  • 17. Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.
    Nock BA, Maina T, Yannoukakos D, Pirmettis IC, Papadopoulos MS, Chiotellis E.
    J Med Chem; 1999 Mar 25; 42(6):1066-75. PubMed ID: 10090789
    [Abstract] [Full Text] [Related]

  • 18. Rhenium(V) and technetium(V) nitrido complexes with mixed tridentate π-donor and monodentate π-acceptor ligands.
    Boschi A, Cazzola E, Uccelli L, Pasquali M, Ferretti V, Bertolasi V, Duatti A.
    Inorg Chem; 2012 Mar 05; 51(5):3130-7. PubMed ID: 22324784
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
    Hayne DJ, White JM, McLean CA, Villemagne VL, Barnham KJ, Donnelly PS.
    Inorg Chem; 2016 Aug 15; 55(16):7944-53. PubMed ID: 27459001
    [Abstract] [Full Text] [Related]

  • 20. Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: synthesis and preliminary evaluation.
    Tsoukalas C, Pirmettis I, Patsis G, Papadopoulos A, Raptopoulou CP, Terzis A, Papadopoulos M, Chiotellis E.
    Nucl Med Biol; 2001 Nov 15; 28(8):975-82. PubMed ID: 11711317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.